<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">helmholtzeyeinstitute</journal-id><journal-title-group><journal-title xml:lang="ru">Российский офтальмологический журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Russian Ophthalmological Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2072-0076</issn><issn pub-type="epub">2587-5760</issn><publisher><publisher-name>Real time Publishers</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21516/2072-0076-2022-15-4-166-172</article-id><article-id custom-type="elpub" pub-id-type="custom">helmholtzeyeinstitute-1117</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРЫ ЛИТЕРАТУРЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEWS</subject></subj-group></article-categories><title-group><article-title>Заболевания щитовидной железы и их роль в патогенезе глаукомы</article-title><trans-title-group xml:lang="en"><trans-title>Thyroid disorders and their role in the pathogenesis of glaucoma</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1361-6704</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чернякова</surname><given-names>Т. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Chernyakova</surname><given-names>T. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Татьяна Васильевна Чернякова — канд. мед. наук, врач-офтальмолог</p><p>Севастопольский проспект, д. 66, Москва, 117593</p></bio><bio xml:lang="en"><p>Tatyana V. Chernyakova — Cand. of Med. Sci., ophthalmologist</p><p> </p></bio><email xlink:type="simple">tat.chernyakova-25@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5965-2471</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Заргарян</surname><given-names>А. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Zargaryan</surname><given-names>H. Y.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Асмик Ерджаниковна Заргарян — канд. мед. наук, врач-офтальмолог</p><p>ул. Пролетарская, д. 7, Балашиха, Московская область, 143980</p></bio><bio xml:lang="en"><p>Hasmik Y. Zargaryan — Cand. of Med. Sci., ophthalmologist</p><p> </p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5597-983X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Брежнев</surname><given-names>А. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Brezhnev</surname><given-names>A. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Андрей Юрьевич Брежнев — канд. мед. наук, доцент кафедры офтальмологии</p><p>ул. Карла Маркса, д. 3, Курск, 305041</p></bio><bio xml:lang="en"><p>Andrey Yu. Brezhnev — Cand. of Med. Sci., associate professor of chair of ophthalmology</p><p> </p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6841-3547</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Онуфрийчук</surname><given-names>О. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Onufriychuk</surname><given-names>O. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Олег Николаевич Онуфрийчук — канд. мед. наук, врач-офтальмолог</p><p>Парковая ул., д. 64–68, Пушкин, Санкт-Петербург, 196603</p></bio><bio xml:lang="en"><p>Oleg N. Onufriychuk — Cand. of Med. Sci., ophthalmologist</p><p> </p></bio><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4611-9931</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Газизова</surname><given-names>И. Р.</given-names></name><name name-style="western" xml:lang="en"><surname>Gazizova</surname><given-names>I. R.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ильмира Рифовна Газизова — д-р мед. наук, ученый секретарь, заведующая отделением офтальмологии</p><p>ул. Академика Павлова, д. 9, Санкт-Петербург, 197376</p></bio><bio xml:lang="en"><p>Ilmira R. Gazizova — Dr. of Med.Sci., scientific secretary, head ofophthalmological department</p><p> </p></bio><xref ref-type="aff" rid="aff-5"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4583-6050</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Селезнев</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Seleznev</surname><given-names>А. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Алексей Владимирович Селезнев — канд. мед. наук, доцент кафедры оториноларингологии и офтальмологии</p><p>пр. Шереметевский, д. 8, Иваново,153012</p></bio><bio xml:lang="en"><p>Аleksey V. Seleznev — Cand. of Med. Sci., assistant professor</p><p> </p></bio><xref ref-type="aff" rid="aff-6"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9606-0566</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Куроедов</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Kuroyedov</surname><given-names>А. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Александр Владимирович Куроедов — д-р мед. наук, профессор кафедры, начальник отделения</p><p>ул. Б. Оленья, д. 8А, Москва, 107014</p><p>ул. Островитянова, д. 1, Москва, 117997</p></bio><bio xml:lang="en"><p>Аleksandr V. Kuroyedov — Dr. of Med. Sci., head of ophthalmological department, professor1, chair of ophthalmology</p></bio><xref ref-type="aff" rid="aff-7"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Многопрофильный медицинский центр Банка России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Multifield Medical Center of Bank of Russia</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Офтальмологическая клиника «Доктор Глазов»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Doctor Glazov Ophthalmology Clinic</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ФГБОУ ВО «Курский государственный медицинский университет» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Kursk State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru"><institution>ФГБУ «НМИЦ детской травматологии и ортопедии им. Г.И. Турнера» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>G.Turner National Medical Research Center for Children’s Orthopedics and Trauma Surgery</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-5"><aff xml:lang="ru"><institution>ФГУН «Институт мозга человека им. Н.П. Бехтеревой» РАН</institution><country>Россия</country></aff><aff xml:lang="en"><institution>N.P. Bekhtereva Institute of Human Brain, RAS</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-6"><aff xml:lang="ru"><institution>ФГБОУ ВО «Ивановская государственная медицинская академия» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Ivanovo State Medical Academy</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-7"><aff xml:lang="ru"><institution>ФГУ «Центральный военный клинический госпиталь им. П.В. Мандрыка» Минздрава России; Российский национальный исследовательский медицинский университет им. Н.И. Пирогова Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Mandryka Central Clinical Hospital; N.I. Pirogov Russian National Research Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>14</day><month>12</month><year>2022</year></pub-date><volume>15</volume><issue>4</issue><fpage>166</fpage><lpage>172</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Чернякова Т.В., Заргарян А.Е., Брежнев А.Ю., Онуфрийчук О.Н., Газизова И.Р., Селезнев А.В., Куроедов А.В., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Чернякова Т.В., Заргарян А.Е., Брежнев А.Ю., Онуфрийчук О.Н., Газизова И.Р., Селезнев А.В., Куроедов А.В.</copyright-holder><copyright-holder xml:lang="en">Chernyakova T.V., Zargaryan H.Y., Brezhnev A.Y., Onufriychuk O.N., Gazizova I.R., Seleznev А.V., Kuroyedov А.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://roj.igb.ru/jour/article/view/1117">https://roj.igb.ru/jour/article/view/1117</self-uri><abstract><p>Анализ литературы подтверждает взаимосвязь патологии щитовидной железы и глаукомы. Пациенты с диффузно-токсическим и эндемическим зобом представляют группу особо высокого риска развития глаукомы, с аутоиммунным тиреоидитом — группу умеренного риска. У пациентов, страдающих эндокринной офтальмопатией, в возрасте старше 40 лет распространенность первичной открытоугольной глаукомы (ПОУГ) достоверно связана с мужским полом и длительностью заболевания более 60 мес. Повышенный риск развития ПОУГ при гипотиреозе отмечен у мужчин со средним возрастом 69 лет. Сопровождающая эндокринную патологию офтальмогипертензия в большинстве случаев не нуждается в местном гипотензивном лечении. Основная патогенетически обоснованная терапия заболеваний щитовидной железы приводит к снижению уровня внутриглазного давления и улучшению оттока жидкости из глаза.</p></abstract><trans-abstract xml:lang="en"><p>The literature analysis confirms the interrelationship of thyroid gland pathology and glaucoma. Patients with diffusetoxic goiter (DTG) and endemic goiter have an especially high risk of developing glaucoma, while those with autoimmune thyroiditis face a moderate risk. The prevalence of primary open angle glaucoma (POAG) in patients over 40 with endocrine ophthalmopathy is reliably associated with the male gender and the duration of the disease longer than 60 months. An increased risk of POAG is noted in men with hypothyroidism averagely aged 69. In most cases, ophthalmic hypertension that accompanies endocrine pathology does not need any topical hypotensive treatment. The main pathogenetically validated therapy of thyroid disorders results in a reduction of IOP level and an improvement of fluid outflow from the eye.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>глаукома</kwd><kwd>внутриглазное давление</kwd><kwd>гипотиреоз</kwd><kwd>болезнь Грейвса</kwd><kwd>гипертиреоз</kwd><kwd>тиреоидные гормоны</kwd></kwd-group><kwd-group xml:lang="en"><kwd>glaucoma</kwd><kwd>intraocular pressure</kwd><kwd>hypothyroidism</kwd><kwd>Graves’ disease</kwd><kwd>hyperthyroidism</kwd><kwd>thyroid hormones</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Егоров Е.А., Еричев В.П., ред. Национальное руководство по глаукоме для практикующих врачей. 4-е изд. Москва: ГЭОТАР-Медиа; 2019.</mixed-citation><mixed-citation xml:lang="en">Egorov E.A., Erichev V.P., eds. National Guidelines for Glaucoma Practitioners. Moscow: GEOTAR-Media; 2019. 4 ed. (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">McLeod D.S., Caturegli P., Cooper D.S., et al. Variation in rates of autoimmune thyroid disease by race/ethnicity in US military personnel. JAMA. 2014; 311 (15): 1563–5. doi:10.1001/jama.2013.285606</mixed-citation><mixed-citation xml:lang="en">McLeod D.S., Caturegli P., Cooper D.S., et al. Variation in rates of autoimmune thyroid disease by race/ethnicity in US military personnel. JAMA. 2014; 311 (15): 1563–5. doi:10.1001/jama.2013.285606</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Garber J.R., Cobin R.H., Gharib H., et al. American Association of Clinical Endocrinologists and American Thyroid Association Taskforce on Hypothyroidism in Adults. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract. 2012; 18 (6): 988–1028. doi:10.4158/EP12280</mixed-citation><mixed-citation xml:lang="en">Garber J.R., Cobin R.H., Gharib H., et al. American Association of Clinical Endocrinologists and American Thyroid Association Taskforce on Hypothyroidism in Adults. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract. 2012; 18 (6): 988–1028. doi:10.4158/EP12280</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Brenta G., Vaisman M., Sgarbi J.A., et al. Task Force on Hypothyroidism of the Latin American Thyroid Society (LATS). Clinical practice guidelines for the management of hypothyroidism. Arq. Bras. Endocrinol. Metabol. 2013; 57 (4): 265–91. doi:10.1590/s0004-27302013000400003</mixed-citation><mixed-citation xml:lang="en">Brenta G., Vaisman M., Sgarbi J.A., et al. Task Force on Hypothyroidism of the Latin American Thyroid Society (LATS). Clinical practice guidelines for the management of hypothyroidism. Arq. Bras. Endocrinol. Metabol. 2013; 57 (4): 265–91. doi:10.1590/s0004-27302013000400003</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Cross J.M., Girkin C.A., Owsley C., et al. The association between thyroid problems and glaucoma. Br. J. Ophthalmol. 2008; 92 (11): 1503–5. https://doi.org/10.1136/bjo.2008.147165</mixed-citation><mixed-citation xml:lang="en">Cross J.M., Girkin C.A., Owsley C., et al. The association between thyroid problems and glaucoma. Br. J. Ophthalmol. 2008; 92 (11): 1503–5. https:// doi.org/10.1136/bjo.2008.147165</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Лихванцева В.Г., Коростелева Е.В., Табеева К.И., Выгодин В.А. Заболевания щитовидной железы как фактор развития первичной открытоугольной глаукомы. Российский медико-биологический вестник им. И.П. Павлова. 2013; 21 (3): 137–42. doi:10.17816/PAVLOVJ20133137-142</mixed-citation><mixed-citation xml:lang="en">Likhvantseva V.G., Korosteleva E.V., Tabeeva K.I. Vygodin V.A. Diseases of thyroid gland as a risk factor in primary open angle glaucoma development. I.P. Pavlov Russian Medical Biological Herald. 2013; 21 (3): 137–42 (in Russian). doi:10.17816/PAVLOVJ20133137-142</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Лихванцева В.Г., Кузьмин К.А., Коростелёва Е.В. и др. Поиск и идентификация рецепторов тиреоидных гормонов в тканях глаза. Офтальмология. 2014; 11 (2): 27–31. https://doi.org/10.18008/1816-5095-2014-2-27-31</mixed-citation><mixed-citation xml:lang="en">Likhvantseva V.G., Kuz'min K.A., Korosteleva E.V., et al. Search and identification of thyroid hormones receptors in ocular tissues. Ophthalmology. 2014; 11 (2): 27–31 (in Russian). https://doi.org/10.18008/1816-5095-2014-2-27-31</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">He J., Wu Z., Yan J., et al. Clinical analysis of 106 cases with elevated intraocular pressure in thyroid-associated ophthalmopathy. Yan Ke Xue Bao. 2004; 20 (1): 10–4.</mixed-citation><mixed-citation xml:lang="en">He J., Wu Z., Yan J., et al. Clinical analysis of 106 cases with elevated intraocular pressure in thyroid-associated ophthalmopathy. Yan Ke Xue Bao. 2004; 20 (1): 10–4.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Алексеев И.Б., Алескерова П.М., Дзиова Ф.С., Мослехи Ш. Особенности внутриглазной гидродинамики у больных эндокринной офтальмопатией. Глаукома. 2010; 9 (2): 3–6.</mixed-citation><mixed-citation xml:lang="en">Alekseev I.B., Aleskerova P.M., Dziova F.S., Moslekhi Sh. Features of intraocular hydrodynamics in patients with endocrine ophthalmopathy. Glaucoma. 2010; 9 (2): 3–6 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Бровкина А.Ф. Эндокринная офтальмопатия. Москва: ГЭОТАР-Медиа; 2008.</mixed-citation><mixed-citation xml:lang="en">Brovkina A.F. Endocrine ophthalmopathy. Moscow: GEOTAR-Media; 2008 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Duncan K.G., Jumper M.D., Ribeiro R.C., et al. Human trabecular meshwork cells as a thyroid hormone target tissue: presence of functional thyroid hormone receptors. Graefes Arch. Clin. Exp. Ophthalmol. 1999; 237 (3): 231–40. doi:10.1007/s004170050224</mixed-citation><mixed-citation xml:lang="en">Duncan K.G., Jumper M.D., Ribeiro R.C., et al. Human trabecular meshwork cells as a thyroid hormone target tissue: presence of functional thyroid hormone receptors. Graefes Arch. Clin. Exp. Ophthalmol. 1999; 237 (3): 231–40. doi:10.1007/s004170050224</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Пантелеева О.Г. Современная концепция механизма развития нарушений зрительных функций при эндокринной офтальмопатии. Международный эндокринологический журнал. 2010; 27 (3): 14–6.</mixed-citation><mixed-citation xml:lang="en">Panteleeva O.G. The modern concept of the mechanism of development of visual dysfunctions in endocrine ophthalmopathy. International Endocrinological Journal. 2010; 27 (3): 14–6 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Лихванцева В.Г., Коростелёва Е.В., Ковеленова И.В. и др. Дефицит глазного кровотока — ключевой фактор, определяющий форму вторичной глаукомы при эндокринной офтальмопатии. Российский офтальмологический журнал. 2016; 9 (3): 43–9. https://doi.org/10.21516/2072-0076-2016-9-3-43-49</mixed-citation><mixed-citation xml:lang="en">Likhvantseva V.G., Korosteleva E.V., Kovelenova I.V., et al. Eye blood flow deficiency is the key factor determining the form of the secondary glaucoma in endocrine ophthalmopath. Russian ophthalmological journal. 2016; 9 (3): 43–9 (in Russian). https://doi.org/10.21516/2072-0076-2016-9-3-43-49</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Киселева Т.Н., Пантелеева О.Г., Шамшинова А.М. Кровоток в сосудах глаза и орбиты у больных эндокринной офтальмопатией. Вестник офтальмологии. 2007; 123 (1): 33–6.</mixed-citation><mixed-citation xml:lang="en">Kiseleva T.N., Panteleeva O.G., Shamshinova A.M. Ocular and orbital vascular blood flow in patients with endocrine ophthalmopathy. Vestnik oftalmologii. 2007; 123 (1): 33–6 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Свириденко Н.Ю., Беловалова И.М., Шеремета М.С. и др. Болезнь Грейвса и эндокринная офтальмопатия. Москва: МАИ-ПРИНТ; 2012.</mixed-citation><mixed-citation xml:lang="en">Sviridenko N.Yu., Belovalova I.M., Sheremeta M.S., et al. Graves' disease and endocrine ophthalmopathy. Moscow: MAI-Print; 2012 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Лихванцева В.Г., Коростелёва Е.В. Нарушение кровоснабжения глаза на фоне первичного гипотиреоза и первичного тиреотоксикоза. Офтальмология. 2019; 16 (3): 329–34. https://doi.org/10.18008/1816-5095-2019-3-329-334</mixed-citation><mixed-citation xml:lang="en">Likhvantseva V.G., Korosteleva E.V. Ischemia of the Eye on the Background of Primary Hypothyroidism and Primary Thyrotoxicosis. Ophthalmology. 2019; 16 (3): 329–34 (in Russian). https://doi.org/10.18008/1816-5095-2019-3-329-334</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Беловалова И.М., Свириденко Н.Ю., Бессмертная Е.Г. и др. Фенотипы эндокринной офтальмопатии: клиническая манифестация и томографические характеристики. Проблемы эндокринологии. 2018; 64 (6): 383–9. https://doi.org/10.14341/probl9618</mixed-citation><mixed-citation xml:lang="en">Belovalova I.M., Sviridenko N.Yu., Bessmertnaya E.G., et al. Phenotypes of endocrine ophthalmopathy: clinical manifestation and tomographic characteristics. Problems of Endocrinology. 2018; 64 (6): 383–9 (in Russian). https://doi.org/10.14341/probl9618</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Ohtsuka K., Nakamura Y. Open-angle glaucoma associated with Graves disease. Am. J. Ophthalmol. 2000; 129 (5): 613–7. doi:10.1016/s0002-9394(99)00473-0</mixed-citation><mixed-citation xml:lang="en">Ohtsuka K., Nakamura Y. Open-angle glaucoma associated with Graves disease. Am. J. Ophthalmol. 2000; 129 (5): 613–7. doi:10.1016/s0002-9394(99)00473-0</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">McKeag D., Lane C., Lazarus J.H., et al. European Group on Graves' Orbitopathy (EUGOGO). Clinical features of dysthyroid optic neuropathy: a European Group on Graves' Orbitopathy (EUGOGO) survey. Br. J. Ophthalmol. 2007; 91 (4): 455–8. doi:10.1136/bjo.2006.094607</mixed-citation><mixed-citation xml:lang="en">McKeag D., Lane C., Lazarus J.H., et al. European Group on Graves' Orbitopathy (EUGOGO). Clinical features of dysthyroid optic neuropathy: a European Group on Graves' Orbitopathy (EUGOGO) survey. Br. J. Ophthalmol. 2007; 91 (4): 455–8. doi:10.1136/bjo.2006.094607</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Eslami F., Borzouei S., Khanlarzadeh E., Seif S. Prevalence of increased intraocular pressure in patients with Graves' ophthalmopathy and association with ophthalmic signs and symptoms in the north-west of Iran. Clin. Ophthalmol. 2019; 13: 1353–9. doi:10.2147/OPTH.S205112</mixed-citation><mixed-citation xml:lang="en">Eslami F., Borzouei S., Khanlarzadeh E., Seif S. Prevalence of increased intraocular pressure in patients with Graves' ophthalmopathy and association with ophthalmic signs and symptoms in the north-west of Iran. Clin. Ophthalmol. 2019; 13: 1353–9. doi:10.2147/OPTH.S205112</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Ohtsuka K. Intraocular pressure and proptosis in 95 patients with Graves ophthalmopathy. Am J Ophthalmol. 1997; 124 (4): 570–2. doi:10.1016/s00029394(14)70883-9</mixed-citation><mixed-citation xml:lang="en">Ohtsuka K. Intraocular pressure and proptosis in 95 patients with Graves ophthalmopathy. Am J Ophthalmol. 1997; 124 (4): 570–2. doi:10.1016/s00029394(14)70883-9</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Etezad-Razavi M., Aboutorabi R.B., Zarei-Ghanavati S., et al. Prevalence and severity of ophthalmic manifestations of Graves’ disease in Mashhad university endocrine clinics. Iran J. Ophthalmol. 2006; 19 (3): 14–21.</mixed-citation><mixed-citation xml:lang="en">Etezad-Razavi M., Aboutorabi R.B., Zarei-Ghanavati S., et al. Prevalence and severity of ophthalmic manifestations of Graves’ disease in Mashhad university endocrine clinics. Iran J. Ophthalmol. 2006; 19 (3): 14–21.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Kim J.W., Ko J., Woo Y.J., et al. Prevalence of ocular hypertension and glaucoma as well as associated factors in Graves' Orbitopathy. J. Glaucoma. 2018; 27 (5): 464–9. doi:10.1097/IJG.0000000000000942</mixed-citation><mixed-citation xml:lang="en">Kim J.W., Ko J., Woo Y.J., et al. Prevalence of ocular hypertension and glaucoma as well as associated factors in Graves' Orbitopathy. J. Glaucoma. 2018; 27 (5): 464–9. doi:10.1097/IJG.0000000000000942</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Cockerham K.P., Pal C., Jani B., et al. The prevalence and implications of ocular hypertension and glaucoma in thyroid-associated orbitopathy. Ophthalmology. 1997; 104 (6): 914–7. doi:10.1016/s0161-6420(97)30207-3</mixed-citation><mixed-citation xml:lang="en">Cockerham K.P., Pal C., Jani B., et al. The prevalence and implications of ocular hypertension and glaucoma in thyroid-associated orbitopathy. Ophthalmology. 1997; 104 (6): 914–7. doi:10.1016/s0161-6420(97)30207-3</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">da Silva F., de Lourdes Veronese Rodrigues M., Akaishi P., et al. Graves' orbitopathy: frequency of ocular hypertension and glaucoma. Eye. 2009; 23 (4): 957–9. https://doi.org/10.1038/eye.2008.155</mixed-citation><mixed-citation xml:lang="en">da Silva F., de Lourdes Veronese Rodrigues M., Akaishi P., et al. Graves' orbitopathy: frequency of ocular hypertension and glaucoma. Eye. 2009; 23 (4): 957–9. https://doi.org/10.1038/eye.2008.155</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Behrouzi Z., Rabei H.M., Azizi F., et al. Prevalence of open-angle glaucoma, glaucoma suspect, and ocular hypertension in thyroid-related immune orbitopathy. J. Glaucoma. 2007; 16 (4): 358–62. doi:10.1097/IJG.0b013e31802e644b</mixed-citation><mixed-citation xml:lang="en">Behrouzi Z., Rabei H.M., Azizi F., et al. Prevalence of open-angle glaucoma, glaucoma suspect, and ocular hypertension in thyroid-related immune orbitopathy. J. Glaucoma. 2007; 16 (4): 358–62. doi:10.1097/IJG.0b013e31802e644b</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Haefliger I.O., von Arx G., Pimentel A.R. Pathophysiology of intraocular pressure increase and glaucoma prevalence in thyroid eye disease: a mini-review. Klin. Monbl. Augenheilkd. 2010; 227 (4): 292–3. doi:10.1055/s-0029-1245199</mixed-citation><mixed-citation xml:lang="en">Haefliger I.O., von Arx G., Pimentel A.R. Pathophysiology of intraocular pressure increase and glaucoma prevalence in thyroid eye disease: a mini-review. Klin. Monbl. Augenheilkd. 2010; 227 (4): 292–3. doi:10.1055/s-0029-1245199</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Chaker L., Bianco A.C., Jonklaas J., Peeters R.P. Hypothyroidism. Lancet. 2017; 390 (10101): 1550–62. doi:10.1016/S0140-6736(17)30703-1</mixed-citation><mixed-citation xml:lang="en">Chaker L., Bianco A.C., Jonklaas J., Peeters R.P. Hypothyroidism. Lancet. 2017; 390 (10101): 1550–62. doi:10.1016/S0140-6736(17)30703-1</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Дедов И.И., Мельниченко Г.А., ред. Эндокринология: национальное руководство. 2-е изд. Москва: ГЭОТАР-Медиа; 2019.</mixed-citation><mixed-citation xml:lang="en">Dedov I.I., Mel'nichenko G.A. Endocrinology: national guidelines. Moscow: GEOTARMedia; 2019 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Garber J.R., Cobin R.H., Gharib H., et al. American Association of Clinical Endocrinologists and American Thyroid Association Taskforce on Hypothyroidism in Adults. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract. 2012; 18 (6): 988–1028. doi:10.4158/EP12280.GL</mixed-citation><mixed-citation xml:lang="en">Garber J.R., Cobin R.H., Gharib H., et al. American Association of Clinical Endocrinologists and American Thyroid Association Taskforce on Hypothyroidism in Adults. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract. 2012; 18 (6): 988–1028. doi:10.4158/EP12280.GL</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Verloop H., Louwerens M., Schoones J.W., et al. Risk of hypothyroidism following hemithyroidectomy: systematic review and meta-analysis of prognostic studies. J. Clin. Endocrinol. Metab. 2012; 97 (7): 2243–55. doi:10.1210/jc.2012-1063</mixed-citation><mixed-citation xml:lang="en">Verloop H., Louwerens M., Schoones J.W., et al. Risk of hypothyroidism following hemithyroidectomy: systematic review and meta-analysis of prognostic studies. J. Clin. Endocrinol. Metab. 2012; 97 (7): 2243–55. doi:10.1210/jc.2012-1063</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Kahraman D., Keller C., Schneider C., et al. Development of hypothyroidism during long-term follow-up of patients with toxic nodular goitre after radioiodine therapy. Clin. Endocrinol. 2012; 76: 297–303. https://doi.org/10.1111/j.13652265.2011.04204.x</mixed-citation><mixed-citation xml:lang="en">Kahraman D., Keller C., Schneider C., et al. Development of hypothyroidism during long-term follow-up of patients with toxic nodular goitre after radioiodine therapy. Clin. Endocrinol. 2012; 76: 297–303. https://doi.org/10.1111/j.13652265.2011.04204.x</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Wang S., Liu Y., Zheng G. Hypothyroidism as a risk factor for open angle glaucoma: A systematic review and meta-analysis. PLoS One. 2017; 12(10): e0186634. doi:10.1371/journal.pone.0186634</mixed-citation><mixed-citation xml:lang="en">Wang S., Liu Y., Zheng G. Hypothyroidism as a risk factor for open angle glaucoma: A systematic review and meta-analysis. PLoS One. 2017; 12(10): e0186634. doi:10.1371/journal.pone.0186634</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Kim M., Kim T.W., Park K.H., Kim J.M. Risk factors for primary open-angle glaucoma in South Korea: the Namil study. Jpn. J. Ophthalmol. 2012; 56 (4): 324–9. doi:10.1007/s10384-012-0153-4</mixed-citation><mixed-citation xml:lang="en">Kim M., Kim T.W., Park K.H., Kim J.M. Risk factors for primary open-angle glaucoma in South Korea: the Namil study. Jpn. J. Ophthalmol. 2012; 56 (4): 324–9. doi:10.1007/s10384-012-0153-4</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Thvilum M., Brandt F., Brix T.H., Heged s L. The interrelation between hypothyroidism and glaucoma: a critical review and meta-analyses. Acta Ophthalmol. 2017; 95 (8): 759–67. doi:10.1111/aos.13412</mixed-citation><mixed-citation xml:lang="en">Thvilum M., Brandt F., Brix T.H., Heged s L. The interrelation between hypothyroidism and glaucoma: a critical review and meta-analyses. Acta Ophthalmol. 2017; 95 (8): 759–67. doi:10.1111/aos.13412</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Lee A.J., Rochtchina E., Wang J.J., et al. Open-angle glaucoma and systemic thyroid disease in an older population: The Blue Mountains Eye Study. Eye (Lond). 2004; 18 (6): 600–8. doi:10.1038/sj.eye.6700731</mixed-citation><mixed-citation xml:lang="en">Lee A.J., Rochtchina E., Wang J.J., et al. Open-angle glaucoma and systemic thyroid disease in an older population: The Blue Mountains Eye Study. Eye (Lond). 2004; 18 (6): 600–8. doi:10.1038/sj.eye.6700731</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Centanni M., Cesareo R., Verallo O. Reversible increase of intraocular pressure in subclinical hypothyroid patients. Eur J Endocrinol. 1997; 136 (6): 595–8. doi:10.1530/eje.0.1360595</mixed-citation><mixed-citation xml:lang="en">Centanni M., Cesareo R., Verallo O. Reversible increase of intraocular pressure in subclinical hypothyroid patients. Eur J Endocrinol. 1997; 136 (6): 595–8. doi:10.1530/eje.0.1360595</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Алексеев И.Б., Иомдина Е.Н., Аливердиева М.А. и др. Заболевания щитовидной железы и первичная открытоугольная глаукома: есть ли связь? Национальный журнал Глаукома. 2017; 16 (2): 63–8.</mixed-citation><mixed-citation xml:lang="en">Alekseev I.B., Iomdina E.N., Aliverdieva M.A., et al. Thyroid gland diseases and primary open-angle glaucoma: are they connected? National Journal glaucoma. 2017; 16 (2): 63–8 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Lin H.C., Kang J.H., Jiang Y.D., Ho J.D. Hypothyroidism and the risk of developing open-angle glaucoma: a five-year population-based follow-up study. Ophthalmology. 2010; 117 (10): 1960–6. doi:10.1016/j.ophtha.2010.02.005</mixed-citation><mixed-citation xml:lang="en">Lin H.C., Kang J.H., Jiang Y.D., Ho J.D. Hypothyroidism and the risk of developing open-angle glaucoma: a five-year population-based follow-up study. Ophthalmology. 2010; 117 (10): 1960–6. doi:10.1016/j.ophtha.2010.02.005</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Girkin C.A., McGwin G.Jr., McNeal S.F,. et al. Hypothyroidism and the development of open-angle glaucoma in a male population. Ophthalmology. 2004; 111 (9): 1649–52. doi:10.1016/j.ophtha.2004.05.026</mixed-citation><mixed-citation xml:lang="en">Girkin C.A., McGwin G.Jr., McNeal S.F,. et al. Hypothyroidism and the development of open-angle glaucoma in a male population. Ophthalmology. 2004; 111 (9): 1649–52. doi:10.1016/j.ophtha.2004.05.026</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Smith K.D., Tevaarwerk G.J., Allen L.H. An ocular dynamic study supporting the hypothesis that hypothyroidism is a treatable cause of secondary open-angle glaucoma. Can. J. Ophthalmol. 1992; 27 (7): 341–4.</mixed-citation><mixed-citation xml:lang="en">Smith K.D., Tevaarwerk G.J., Allen L.H. An ocular dynamic study supporting the hypothesis that hypothyroidism is a treatable cause of secondary open-angle glaucoma. Can. J. Ophthalmol. 1992; 27 (7): 341–4.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Knepper P.A., Covici S., Fadel J.R., Mayanil C.S., Ritch R. Surface-tension properties of hyaluronic Acid. J. Glaucoma. 1995; 4 (3): 194–9.</mixed-citation><mixed-citation xml:lang="en">Knepper P.A., Covici S., Fadel J.R., Mayanil C.S., Ritch R. Surface-tension properties of hyaluronic Acid. J. Glaucoma. 1995; 4 (3): 194–9.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Guo M.S., Wu Y.Y., Liang Z.B. Hyaluronic acid increases MMP-2 and MMP-9 expressions in cultured trabecular meshwork cells from patients with primary open-angle glaucoma. Mol. Vis. 2012; 18: 1175–81.</mixed-citation><mixed-citation xml:lang="en">Guo M.S., Wu Y.Y., Liang Z.B. Hyaluronic acid increases MMP-2 and MMP-9 expressions in cultured trabecular meshwork cells from patients with primary open-angle glaucoma. Mol. Vis. 2012; 18: 1175–81.</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Stein R., Romano A., Treister G., Bartov E. Effect of subconjunctival injection of hyaluronidase on outflow resistance in normal and in open-angle glaucomatous patients. Metab. Pediatr. Syst. Ophthalmol. 1982; 6 (3–4): 169–74.</mixed-citation><mixed-citation xml:lang="en">Stein R., Romano A., Treister G., Bartov E. Effect of subconjunctival injection of hyaluronidase on outflow resistance in normal and in open-angle glaucomatous patients. Metab. Pediatr. Syst. Ophthalmol. 1982; 6 (3–4): 169–74.</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Kakigi C., Kasuga T., Wang S.Y., et al. Hypothyroidism and Glaucoma in The United States. PLoS One. 2015; 10 (7): e0133688. https://doi.org/10.1371/journal.pone.0133688</mixed-citation><mixed-citation xml:lang="en">Kakigi C., Kasuga T., Wang S.Y., et al. Hypothyroidism and Glaucoma in The United States. PLoS One. 2015; 10 (7): e0133688. https://doi.org/10.1371/journal.pone.0133688</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Motsko S.P., Jones J.K. Is there an association between hypothyroidism and open angle glaucoma in an elderly population? An epidemiologic study Ophthalmology. 2008; 115 (9): 1581–4. doi:https://doi.org/10.1016/j.ophtha.2008.01.016</mixed-citation><mixed-citation xml:lang="en">Motsko S.P., Jones J.K. Is there an association between hypothyroidism and open angle glaucoma in an elderly population? An epidemiologic study Ophthalmology. 2008; 115 (9): 1581–4. doi:https://doi.org/10.1016/j.ophtha.2008.01.016</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Grus F.H., Joachim S.C., Bruns K., et al. Serum autoantibodies to alpha-fodrin are present in glaucoma patients from Germany and the United States. Invest. Ophthalmol. Vis. Sci. 2006; 47 (3): 968–76. doi:10.1167/iovs.05-0685</mixed-citation><mixed-citation xml:lang="en">Grus F.H., Joachim S.C., Bruns K., et al. Serum autoantibodies to alpha-fodrin are present in glaucoma patients from Germany and the United States. Invest. Ophthalmol. Vis. Sci. 2006; 47 (3): 968–76. doi:10.1167/iovs.05-0685</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Boelaert K., Newby P.R., Simmonds M.J., et al. Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease. Am. J. Med. 2010; 123 (2): 183.e 1–9. doi:10.1016/j.amjmed.2009.06.030</mixed-citation><mixed-citation xml:lang="en">Boelaert K., Newby P.R., Simmonds M.J., et al. Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease. Am. J. Med. 2010; 123 (2): 183.e 1–9. doi:10.1016/j.amjmed.2009.06.030</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Brix T.H., Heged s L. Twin studies as a model for exploring the aetiology of autoimmune thyroid disease. Clin. Endocrinol. (Oxf). 2012; 76 (4): 457–64. doi:10.1111/j.1365-2265.2011.04318.x</mixed-citation><mixed-citation xml:lang="en">Brix T.H., Heged s L. Twin studies as a model for exploring the aetiology of autoimmune thyroid disease. Clin. Endocrinol. (Oxf). 2012; 76 (4): 457–64. doi:10.1111/j.1365-2265.2011.04318.x</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Calissendorff J., Ljung R. Thyroxin substitution and open-angle glaucoma: a nationwide register-based study on filled prescriptions. Br. J. Ophthalmol. 2011; 95 (4): 592–4. doi:10.1136/bjo.2010.195032</mixed-citation><mixed-citation xml:lang="en">Calissendorff J., Ljung R. Thyroxin substitution and open-angle glaucoma: a nationwide register-based study on filled prescriptions. Br. J. Ophthalmol. 2011; 95 (4): 592–4. doi:10.1136/bjo.2010.195032</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Thvilum M., Brandt F., Brix T.H., Heged s L. No evidence of a causal relationship between hypothyroidism and glaucoma: A Danish nationwide register-based cohort study. PLoS One. 2018; 13 (2): e0192311. doi:10.1371/journal.pone.0192311</mixed-citation><mixed-citation xml:lang="en">Thvilum M., Brandt F., Brix T.H., Heged s L. No evidence of a causal relationship between hypothyroidism and glaucoma: A Danish nationwide register-based cohort study. PLoS One. 2018; 13 (2): e0192311. doi:10.1371/journal.pone.0192311</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Won Y.S., Kim D.Y., Kim J.M. Glaucomatous Optic Nerve Changes and Thyroid Dysfunction in an Urban South Korean Population. J. Ophthalmol. 2017; 2017: 8280209. doi:10.1155/2017/8280209</mixed-citation><mixed-citation xml:lang="en">Won Y.S., Kim D.Y., Kim J.M. Glaucomatous Optic Nerve Changes and Thyroid Dysfunction in an Urban South Korean Population. J. Ophthalmol. 2017; 2017: 8280209. doi:10.1155/2017/8280209</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Gillow J.T., Shah P., O'Neill E.C. Primary open angle glaucoma and hypothyroidism: chance or true association? Eye (Lond). 1997; 11 (Pt 1): 113–4. doi:10.1038/eye.1997.22</mixed-citation><mixed-citation xml:lang="en">Gillow J.T., Shah P., O'Neill E.C. Primary open angle glaucoma and hypothyroidism: chance or true association? Eye (Lond). 1997; 11 (Pt 1): 113–4. doi:10.1038/eye.1997.22</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Ulas F., Dogan ., Dikbas O., et al. Investigation of the choroidal thickness in patients with hypothyroidism. Indian J. Ophthalmol. 2015; 63 (3): 244–9. doi:10.4103/0301-4738.156976</mixed-citation><mixed-citation xml:lang="en">Ulas F., Dogan ., Dikbas O., et al. Investigation of the choroidal thickness in patients with hypothyroidism. Indian J. Ophthalmol. 2015; 63 (3): 244–9. doi:10.4103/0301-4738.156976</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Yang H.S., Ye H.J. Whether lowering intraocular pressure is needed for thyroid associated ophthalmopathy with intraocular hypertension. Zhonghua Yan Ke Za Zhi. 2019; 55 (11): 811–3. doi:10.3760/cma.j.issn.0412-4081.2019.11.004</mixed-citation><mixed-citation xml:lang="en">Yang H.S., Ye H.J. Whether lowering intraocular pressure is needed for thyroid associated ophthalmopathy with intraocular hypertension. Zhonghua Yan Ke Za Zhi. 2019; 55 (11): 811–3. doi:10.3760/cma.j.issn.0412-4081.2019.11.004</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">McDaniel D., Besada E. Hypothyroidism-a possible etiology of open-angle glaucoma. J. Am. Optom. Assoc. 1996; 67 (2): 109–14.</mixed-citation><mixed-citation xml:lang="en">McDaniel D., Besada E. Hypothyroidism-a possible etiology of open-angle glaucoma. J. Am. Optom. Assoc. 1996; 67 (2): 109–14.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
